Related Experiment Videos
A growing relationship between genomic imprinting and tumorigenesis
A Hochberg1, B Gonik, R Goshen
1Department of Biological Chemistry, Hebrew University of Jerusalem, Israel.
Cancer Genetics and Cytogenetics
|March 1, 1994
Summary
Gene imprinting, the regulation of gene expression based on origin, can drive cancer. Aberrant activation of imprinted genes, like proto-oncogenes, contributes to tumor development and growth.
Area of Science:
- Genetics
- Cancer Biology
- Genomic Imprinting
Background:
- The link between human genome abnormalities and cancer is well-documented.
- Gene imprinting, where expression depends on the gamete of origin, is implicated in cancer via loss of tumor suppressor gene control.
Purpose of the Study:
- To propose that the activation of imprinted proto-oncogenes and growth factors is crucial in tumorigenesis.
- To highlight the mechanism of escaping repression by removal from imprinted sequences.
- To suggest using synteny between human and mouse genomes for studying cancer-related imprinted genes.
Main Methods:
- Literature review on gene imprinting and cancer.
- Hypothesis generation based on existing knowledge.
- Comparative genomics (human-mouse synteny) for targeted gene studies.
Main Results:
- Established role of imprinting in tumor suppressor gene regulation.
- Proposed novel role for imprinted proto-oncogene and growth factor activation in cancer.
- Identified escaping repression as a key mechanism.
- Highlighted the utility of synteny for research.
Conclusions:
- Aberrant activation of imprinted genes, beyond tumor suppressors, is a significant factor in tumorigenesis.
- Loss of genomic imprinting regulation can lead to cancer development.
- Comparative genomics offers a powerful approach to investigate these imprinted genes in cancer research.